St Jude to invest up to $200 million in arrhythmia firm Epicor
This article was originally published in Clinica
Executive Summary
St Jude Medical (St Paul, Minnesota) has invested $15m in a minority interest in Epicor Medical, of Sunnyvale California. It says it has also reserved the right to pay a further $185m to buy Epicor outright in 2004, if the latter's high intensity focused ultrasound (HIFU) minimally invasive ablation system to treat atrial fibrillation (AF) meets certain clinical and regulatory milestones.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.